Upturn unsubscribed user
$1.14/ day, billed weekly
Cancel anytime
(Ad-Free, Unlimited access)​
NO CREDIT CARD REQUIRED
IINNW
Upturn stock ratingUpturn stock rating

Inspira Technologies Oxy B.H.N. Ltd. Warrant (IINNW)

Upturn stock ratingUpturn stock rating
$0.22
Last Close (24-hour delay)
upturn advisory
PASS
  • BUY Advisory
  • SELL Advisory (Profit)​
  • SELL Advisory (Loss)​
  • Profit
  • Loss
  • Pass (Skip investing)
Upturn Stock infoUpturn Stock info Stock price based on last close
*as per simulation
(see disclosures)
Time period over
  • ALL
  • YEAR
  • MONTH
  • WEEK

Upturn Advisory Summary

06/27/2025: IINNW (1-star) is currently NOT-A-BUY. Pass it for now.

Upturn Star Rating

rating

Not Recommended Performance

These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.

Number of Analysts

rating

Analysts rated it

Very few follow this stock; limited insights, higher-risk early investing.

1 Year Target Price $0

1 Year Target Price $0

Analysts Price Target For last 52 week
$0Target price
Low$
Current$0.22
high$

Analysis of Past Performance

Type Stock
Historic Profit 81.68%
Avg. Invested days 37
Today’s Advisory PASS
Upturn Star Rating Upturn stock ratingUpturn stock rating
Upturn Advisory Performance Upturn Advisory Performance 3.0
Stock Returns Performance Upturn Returns Performance 4.0
Upturn Profits based on simulationUpturn Profits based on simulation Profits based on simulation
Upturn Profits based on simulationUpturn Profits based on simulation Last Close 06/27/2025

Key Highlights

Company Size ETF
Market Capitalization 0 USD
Price to earnings Ratio -
1Y Target Price -
Price to earnings Ratio -
1Y Target Price -
Volume (30-day avg) -
Beta 2.12
52 Weeks Range 0.12 - 0.99
Updated Date 06/14/2025
52 Weeks Range 0.12 - 0.99
Updated Date 06/14/2025
Dividends yield (FY) -
Basic EPS (TTM) -3.67

Earnings Date

Report Date -
When -
Estimate -
Actual -

Profitability

Profit Margin -
Operating Margin (TTM) -

Management Effectiveness

Return on Assets (TTM) -81.03%
Return on Equity (TTM) -219.74%

Valuation

Trailing PE -
Forward PE -
Enterprise Value -
Price to Sales(TTM) -
Enterprise Value -
Price to Sales(TTM) -
Enterprise Value to Revenue -
Enterprise Value to EBITDA -
Shares Outstanding -
Shares Floating 24090830
Shares Outstanding -
Shares Floating 24090830
Percent Insiders -
Percent Institutions -

Analyst Ratings

Rating -
Target Price -
Buy -
Strong Buy -
Buy -
Strong Buy -
Hold -
Sell -
Strong Sell -
Strong Sell -

ai summary icon Upturn AI SWOT

Inspira Technologies Oxy B.H.N. Ltd. Warrant

stock logo

Company Overview

overview logo History and Background

Inspira Technologies Oxy B.H.N. Ltd. is a medical technology company specializing in respiratory support technology. The Warrant, INSP.WS, gives the holder the right to purchase shares of INSP stock at a specified price within a specific period.

business area logo Core Business Areas

  • Respiratory Support Technology: Development and commercialization of respiratory support devices, primarily focusing on early intervention and less invasive solutions.

leadership logo Leadership and Structure

Inspira Technologies is led by a management team with experience in medical device development and commercialization. The organizational structure is typical of a publicly traded company, with a board of directors overseeing management.

Top Products and Market Share

overview logo Key Offerings

  • ARTRA: A less invasive respiratory support system designed to prevent the need for mechanical ventilation. Market share is currently negligible as the product is in pre-commercialization. Competitors include traditional ventilator manufacturers (e.g., Medtronic, Hamilton Medical) and companies developing alternative respiratory support devices.

Market Dynamics

industry overview logo Industry Overview

The respiratory support device market is driven by factors such as an aging population, increasing prevalence of respiratory diseases, and technological advancements. The market is competitive with established players and emerging companies offering innovative solutions.

Positioning

Inspira Technologies aims to disrupt the respiratory support market with its less invasive ARTRA system. Their competitive advantage lies in its potential to reduce the need for mechanical ventilation and associated complications.

Total Addressable Market (TAM)

The total addressable market for respiratory support devices is estimated to be in the billions of dollars. Inspira Technologies is positioned to capture a share of this market with its ARTRA system, targeting early intervention and less invasive respiratory support.

Upturn SWOT Analysis

Strengths

  • Innovative technology (ARTRA system)
  • Potential to reduce need for mechanical ventilation
  • Focus on early intervention

Weaknesses

  • Pre-commercialization stage
  • Limited market presence
  • Dependence on regulatory approvals
  • Limited financial resources

Opportunities

  • Growing demand for less invasive respiratory support solutions
  • Partnerships with hospitals and healthcare providers
  • Expansion into new markets
  • Technological advancements in respiratory care

Threats

  • Competition from established players
  • Regulatory hurdles
  • Reimbursement challenges
  • Technological obsolescence

Competitors and Market Share

competitor logo Key Competitors

  • Medtronic (MDT)
  • Hamilton Medical (Private)
  • Getinge (GETI-B.ST)

Competitive Landscape

Inspira Technologies faces significant competition from established players with greater resources and market presence. Its success depends on the ability to differentiate its ARTRA system and secure market adoption.

Growth Trajectory and Initiatives

Historical Growth: Historical growth is limited due to pre-commercialization status.

Future Projections: Future growth is dependent on successful commercialization of the ARTRA system and securing partnerships. Analyst estimates should be consulted for specific projections.

Recent Initiatives: Recent initiatives include securing regulatory approvals and establishing manufacturing partnerships.

Summary

Inspira Technologies is a pre-commercialization company with an innovative respiratory support system that has the potential to disrupt the market. Their strength lies in the ARTRA system's potential to be less invasive. However, it faces significant challenges related to competition, regulatory approvals, and limited financial resources. Successful commercialization and partnerships are crucial for future growth.

Peer Comparison

Sources and Disclaimers

Data Sources:

  • Company SEC filings
  • Industry reports
  • Analyst research reports

Disclaimers:

This analysis is for informational purposes only and does not constitute financial advice. Investment decisions should be based on individual research and consultation with a financial professional. Market share estimates are approximate and based on publicly available information.

Upturn AI SummarizationUpturn AI Summarization AI Summarization is directionally correct and might not be accurate.

Upturn AI SummarizationUpturn AI Summarization Summarized information shown could be a few years old and not current.

Upturn AI SummarizationUpturn AI Summarization Fundamental Rating based on AI could be based on old data.

Upturn AI SummarizationUpturn AI Summarization AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.

About Inspira Technologies Oxy B.H.N. Ltd. Warrant

Exchange NASDAQ
Headquaters -
IPO Launch date 2021-07-14
Co-Founder, CEO & Director Mr. Dagi Shahar Ben-Noon
Sector Healthcare
Industry Medical Devices
Full time employees 37
Full time employees 37

Inspira Technologies Oxy B.H.N. Ltd., a specialty medical device company, engages in the research, development, manufacturing, and marketing of proprietary life support technologies for the treatment of acute respiratory failure in Israel. It offers INSPIRA ART100, a life support system used in procedures requiring cardiopulmonary bypass for six hours or less. The company was formerly known as Insense Medical Ltd. and changed its name to Inspira Technologies Oxy B.H.N. Ltd. in July 2020. Inspira Technologies Oxy B.H.N. Ltd. was incorporated in 2018 and is headquartered in Ra'anana, Israel.